Nomura: Luye Pharma Group (01093.HK) first quarter profit up 47%, raises target price to HK$8.02.

According to the Wisdom Finance APP, Nomura released a research report stating that the target price of CSPC Pharmaceutical Group (01093.HK) has been raised from 6.55 Hong Kong dollars to 8.02 Hong Kong dollars, with a "buy" rating. The bank expects CSPC Pharmaceutical Group's first quarter profit to increase by 47% this year, while revenue is expected to fall by 2% to 8.8 billion yuan.